Provider comparison builder
Compare any two GLP-1 providers on price, doses, pharmacy disclosure and support.
Pick two providers to compare their published figures side by side.
Jastreboff AM et al., N Engl J Med 2022 (NCT04184622), n=2,539. Dose-response is real: the effect rises with dose. These are FDA-APPROVED SUBCUTANEOUS INJECTION doses — they do not transfer to compounded, microdose or ODT products. Trial means are not individual promises.
What this tool calculates, and the formula behind it
Every figure this tool produces uses the same formula as our editorial pages, drawn from the same dataset. There is no separate “marketing” number.
Effective monthly cost = total mandatory payments ÷ months supplied.
| Input | Why it counts |
|---|---|
| Advertised price | The starting point — and usually the most misleading number available. |
| Number of months | A 12-month plan and a month-to-month plan are not the same product. |
| Membership fee | If you cannot decline it, it is part of the price. Roughly half the market splits it out. |
| Consultation fee | Charged separately by some providers; invisible in most comparison tables. |
| Laboratory fee | Some programmes require labs and bill them; others include them. |
| Shipping | Free at some providers, billed at others. |
| Onboarding fee | A one-off charge that is amortised across the plan, not ignored. |
| Dose surcharge | The big one. A flat-rate programme and an escalating one can differ by thousands a year at maintenance. |
| Renewal price | What you pay from month two. This is the number that matters. |
| Discount / coupon | Applied only where the eligibility is stated. |
Assumptions and limitations
- Assumes you complete the plan. Early cancellation terms vary enormously and are not modelled — get them in writing before committing.
- Assumes the advertised ongoing price is accurate. Where we have not captured a price ourselves it is labelled Reported, not Verified.
- Does not model a dose change mid-plan on an escalating programme — ask the provider what you will pay at your target maintenance dose.
- Does not model insurance. If your plan covers brand Zepbound, the savings card can bring it to roughly $25/month, which beats every cash option here.
Privacy
This tool runs entirely in your browser. Nothing you enter is transmitted, stored or logged. We do not collect health information through any tool, form or search on this site.
Frequently asked questions
Are these prices verified?
Provider prices shown in our tools are captured from provider sites and major publishers and labeled with a verification status and date. Only first-party captures are marked Verified; always confirm current pricing on the provider’s own site before enrolling.
Does this tool give medical advice?
No. Our calculators and checklists are educational and help you compare cost and program features. Eligibility and treatment decisions are made by a licensed clinician.
How is effective monthly cost calculated?
Total mandatory payments for the treatment period — medication plus required membership, labs, shipping, onboarding, and dose surcharges — divided by months supplied. See our affordability methodology.
How the comparison is built
This tool compares programs on the same normalized basis used throughout Semaglutide Watchdog: effective monthly cost after mandatory fees, dose-pricing structure, membership requirement, commitment length, pharmacy disclosure, and verification status. Every figure carries an evidence status — Verified for first-party captures, Provider Reported for provider-stated figures, or Verification Pending — so you can weigh how well-supported each claim is.
How to read the results
Sort by effective monthly cost to see the true price ranking rather than the advertised one. A program with a low medication price but a required membership will rank lower once normalized. Pay attention to the dose-pricing column: a flat-rate program holds one price across all doses, while a tiered program raises the cost as you titrate to a maintenance dose. And note the verification status — a Provider Reported figure is the provider's own claim, not an independently confirmed price.
Limitations
The comparison reflects data captured in July 2026 and provider pricing changes frequently; confirm current terms on each provider's own site before enrolling. Only NexLife pricing is first-party Verified in the current evidence ledger; competitor figures are Provider Reported or Verification Pending. This tool does not provide medical advice or a treatment recommendation. Last reviewed July 2026.